Compare CryoPort, Inc. with Similar Stocks
Stock DNA
Transport Services
USD 550 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.45
-10.02%
1.07
Revenue and Profits:
Net Sales:
44 Million
(Quarterly Results - Sep 2025)
Net Profit:
-7 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
85.53%
0%
85.53%
6 Months
5.06%
0%
5.06%
1 Year
-22.49%
0%
-22.49%
2 Years
-57.46%
0%
-57.46%
3 Years
-64.92%
0%
-64.92%
4 Years
-85.54%
0%
-85.54%
5 Years
-66.99%
0%
-66.99%
CryoPort, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
39.78%
EBIT Growth (5y)
-183.52%
EBIT to Interest (avg)
-9.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.30
Tax Ratio
1.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.88
EV to EBIT
-5.19
EV to EBITDA
-10.74
EV to Capital Employed
0.87
EV to Sales
1.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.69%
ROE (Latest)
-14.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 50 Schemes (40.7%)
Foreign Institutions
Held by 78 Foreign Institutions (20.75%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
44.20
45.50
-2.86%
Operating Profit (PBDIT) excl Other Income
-3.50
-2.30
-52.17%
Interest
0.50
0.60
-16.67%
Exceptional Items
1.10
-0.10
1,200.00%
Consolidate Net Profit
-6.70
-12.00
44.17%
Operating Profit Margin (Excl OI)
-223.70%
-211.60%
-1.21%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -2.86% vs 10.98% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 44.17% vs -33.33% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
228.40
233.30
-2.10%
Operating Profit (PBDIT) excl Other Income
-37.20
-31.20
-19.23%
Interest
4.10
5.50
-25.45%
Exceptional Items
-45.30
-49.50
8.48%
Consolidate Net Profit
-114.80
-99.60
-15.26%
Operating Profit Margin (Excl OI)
-297.80%
-251.40%
-4.64%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.10% vs -1.69% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -15.26% vs -167.02% in Dec 2023
About CryoPort, Inc. 
CryoPort, Inc.
Transport Services
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services the Company enable its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions.
Company Coordinates 
Company Details
112 Westwood Pl Ste 350 , BRENTWOOD TN : 37027-5332
Registrar Details






